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In this issue of Neuron, Malhotra and colleagues report an enrichment of de novo copy number variants in
bipolar disorder and schizophrenia when compared with those of controls. The study highlights the impor-
tance of a geneticmodel involving rare and disruptive variants to further our understanding of complex neuro-
psychiatric traits.Identification of novel, rare variants occur-
ring exclusively among affected probands
has contributed to the discovery of
several copy number variants (CNVs)
associated with intellectual disability
(Cooper et al., 2011; Kaminsky et al.,
2011), schizophrenia (Xu et al., 2008),
and autism (Sanders et al., 2011). These
findings have led to screens for large
CNVs in a variety of other neuropsychi-
atric conditions, with less clear results
regarding the overall contribution of
CNVs. In this issue of Neuron, Malhotra
and colleagues (Malhotra et al., 2011)
have extended the paradigm, reporting
an enrichment of de novo CNVs in individ-
uals with bipolar disorder and schizo-
phrenia when compared with controls.
Bipolar disorder is associated with
episodic mood disturbances, including
extreme elation or mania to severe
depression with high lifetime risks of
suicide. Although there is a high degree
of heritability, familial aggregation, and
a lifetime prevalence as high as 4% (Kess-
ler et al., 2005), the complex genetics of
bipolar disorder has been a tough nut to
crack for a number of reasons. Genome-
wide association studies based on
common genetic variants have yielded
relatively few candidate genes that have
withstood replication. Previous screens
for CNVs and CNV burden among bipolar
patients have given conflicting results
with CNV enrichments observed in some
studies but not others. Finally, family-
based studies have given inconsistent
results with respect to segregation of
specific diagnoses (Owen et al., 2007).
The heterogeneity of clinical presenta-tions coupled with our limited under-
standing of the pathogenesis and con-
siderable overlap with symptoms of
schizophrenia have called into question
the traditional ‘‘Kraepelinian’’ dichoto-
mous classification of bipolar disorder
and schizophrenia (Owen et al., 2007).
Indeed, one of the largest population-
based surveys of schizophrenia and
bipolar disorder found significant
evidence of comorbidity within families—
most of which (63%) was explained by
additive genetic effects (Lichtenstein
et al., 2009).
Based on the hypothesis that sporadic,
disruptive mutations are an important
risk factor for bipolar disorder and schizo-
phrenia, Malhotra’s strategy for bipolar
disorder was to search for de novo CNVs
enriching for cases with an earlier age of
onset—a tried and true approach taken
directly from the human genetics play-
book. The authors found about five times
the rate of de novo CNVs in individuals
with bipolar disorder (8/185, 4.3%) and
schizophrenia (8/177, 4.5%) compared
with that of controls (4/426, 0.9%). As pre-
dicted, the rate was slightly higher (6/107,
5.6%) for patients with an earlier age of
onset of symptoms (<18 years), intimating
a neurodevelopmental basis for at least
a subset of thedisease. Similar to previous
observations from other neurodevelop-
mental disorders, a significant enrichment
was also observed for larger (>500 kbp) in-
herited duplications for familial cases of
bipolar disorder, but this trend was not
observed for deletions.
The bipolar-disorder-associated CNVs
identified by Malhotra and colleaguesNeuron 72, Dmay be considered in two different
contexts: individual CNVs corresponding
to specific loci and collectively as an
estimate of overall CNV burden (Figure 1).
With respect to the former, two of the
ten de novo CNVs observed among
the bipolar patients correspond to ge-
nomic hotspots—regions bracketed by
segmental duplications (Sharp et al.,
2006). Because of their predisposition
to recurrent mutations as a result of
nonallelic homologous recombination,
de novo events within these regions
occur frequently enough such that they
can be assessed for their exclusivity to
bipolar disorder compared with other
disorders. Although none of these
specific CNVs could be replicated in
a larger collection of bipolar disorder
patients (2,777 bipolar cases versus
3,508 controls), two hotspot de novo
CNVs (the 16p11.2 duplication and
3q29 deletion) are well known and have
been previously associated with intellec-
tual disability/multiple congenital anoma-
lies (ID/MCA), autism, and schizophrenia
(Cooper et al., 2011; McCarthy et al.,
2009; Mulle et al., 2010). Similarly, an
inherited hotspot variant included the
1q21.1 duplication previously associated
with autism and ID/MCA (Cooper et al.,
2011; Kaminsky et al., 2011). With the
exception of the 9p24 duplication also
reported in schizophrenia individuals (Xu
et al., 2008), several nonhotspot CNVs
are singleton events and, therefore,
warrant further investigation. While po-
tentially important to our understanding
of the genetics of psychosis, there is little
evidence that the most likely pathogenicecember 22, 2011 ª2011 Elsevier Inc. 885
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Figure 1. Shared CNVs and Comparison of Large CNV Burden in Neuropsychiatric Disorders
(A) The histogram shows the frequency (in percentage) of known disease-associated hotspot CNVs (de novo and inherited) discovered in the bipolar cohort.
The frequency of each CNV was obtained from published studies (Cooper et al., 2011; McCarthy et al., 2009; Mulle et al., 2010; Sanders et al., 2011).
(B) The population frequency of the largest, rare CNVs is shown for schizophrenia, bipolar disorder, and controls (Malhotra et al., 2011), along with autism and
ID/MCA (Girirajan et al., 2011). The data from Malhotra and colleagues (Malhotra et al., 2011) was downsampled and size selected (>500 kbp) to allow cross-
platform array comparisons.
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Previewsevents reported in this study are specific
to bipolar disorder.
An assessment of total, rare CNV
burden and comparison with those with
autism and ID phenotypes (Girirajan
et al., 2011) suggest some interesting
trends as well as potential insights into
disease. It is noteworthy, for example,
that de novo bipolar CNVs tend to be
smaller (median size 137 kbp) than de
novo schizophrenia CNVs (415 kbp). The
ability to detect smaller CNVs stems, in
part, from the authors’ use of a higher-
density microarray (2.1 million probes),
allowing them to detect CNVs >10 kbp in
size. There is an excess of both de novo
and inherited duplications as opposed to
deletions in bipolar patients when
compared with schizophrenia patients.
Finally, the overall rare CNV burden is
more modest for bipolar disorder, with
both schizophrenia and autism showing
an increase in the number of larger
CNVs. All of these lines of evidence
suggest CNVs with more subtle and less
severe effects among bipolar patients as
opposed to those with ID, autism, and
schizophrenia. Caution, however, must
be employed because much larger
sample sizes are required to replicate
these findings.
How do we reconcile the lack of CNV
specificity and the modest CNV burden
with the significant increase in de novo886 Neuron 72, December 22, 2011 ª2011 ECNVs among bipolar cases? Increased
CNV size and burden have been shown
to be associated with ID in individuals
with autism (Girirajan et al., 2011) and
there is a general trend that the larger
the CNV event, the greater the number
of genes affected and the more severe
the outcome (Cooper et al., 2011; Girira-
jan et al., 2011). The burden of large
(>500 kbp) CNVs is highest among cases
of ID/MCA (Girirajan et al., 2011) and
decreases for autism, schizophrenia,
and bipolar disorder (Malhotra et al.,
2011; Sanders et al., 2011) (Figure 1B).
Some conditions, such as dyslexia,
show no evidence of increased rates or
burden of CNVs. It follows that for ‘‘less
severe’’ adult phenotypes, such as
bipolar disorder, de novo CNVs might be
smaller in size, affecting fewer genes
and/or manifesting as an excess of dupli-
cations. It is well known that certain CNVs
are much more variable in their outcome,
having been associated with a diverse
range of phenotypes, and that the transi-
tion to ID among pediatric cases associ-
ates with a significant excess of additional
CNVs, so-called second ‘‘hits’’ (Girirajan
et al., 2011). It is, therefore, conceivable
that a subset of bipolar disorder and
schizophrenia are part of a spectrum of
neurodevelopmental disease where the
effects of both de novo and inherited,
rare, gene-disruptive and gene-imbal-lsevier Inc.ance events are additive. Depending on
the underlying genes and their down-
stream interactions, as the total number
of events increases, different thresholds
are passed, resulting in outcomes ranging
from bipolar disorder to schizophrenia to
autism to ID. Comorbidity of these traits
within families is the natural extension of
this model (Lichtenstein et al., 2009;
Woodberry et al., 2008). If these trends
continue, there is reason to hope that
smaller, disruptive CNVs, as well as de
novo point mutations, may unveil a larger
fraction of the genetic etiology of neuro-
psychiatric disease, as has been sug-
gested by preliminary exome sequencing
studies of autism and schizophrenia
(O’Roak et al., 2011; Xu et al., 2011).
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In this issue ofNeuron, Makino andMalinow and Kleindienst et al. present evidence of a behaviorally induced
form of synaptic plasticity that would encourage the development of fine-scale structured input patterns
and the binding of features within single neurons.Input processing and storage within
dendrites is at the heart of neuronal
computation. Yet our understanding of
the fundamental operations performed
by neurons is incomplete and continues
to evolve. Neurons possess numerous
mechanisms that allow them to uniquely
respond to and store distinct synaptic
input patterns, and these capabilities
could be used to produce behaviorally
related network ensemble activity. Thus
the exact level of structure present
in normal-experience-induced input pat-
terns remains an important but unre-
solved issue for which there is both insuf-
ficient and conflicting data. While there
is strong evidence of topographically
organized inputs onto the dendrites of
neurons in several species, such organi-
zation has not yet been observed in
mammalian brain regions (reviewed in
DeBello, 2008; Branco and Ha¨usser,
2010). Two papers in this issue of Neuron
are relevant in that they provide evidencerelated to the type of synaptic plasticity
that could lead to the development of
highly structured input patterns in mam-
malian neurons.
Makino and Malinow (2011) present
evidence that LTP-like synaptic plasticity
induced by sensory experience occurs in
a clustered spatial pattern in pyramidal
neurons of the barrel cortex. The authors
used fluorescently tagged AMPA recep-
tors to monitor activity-dependent AMPA
receptor trafficking in mice with intact
whiskers and found that GluR1 subunits
were enriched in groups of neighboring
spines that were located in an 10 mm
region of a dendritic branch. GluR2
subunits did not show this same enrich-
ment pattern. The tagged GluR1 subunits
present in spines show a relatively low
mobility, suggesting that the enrichment
is due to synaptic incorporation of addi-
tional receptors, as would be expected
for an LTP-type process. Thus, it appears
that a clustered form of synaptic potentia-tion is produced by normal neuronal
activity patterns. This result is contrasted
with that produced by a second experi-
mental condition where sensory depriva-
tion (induced by whisker trimming) was
instead associated with a spine enrich-
ment of GluR2 subunits (but not GluR1)
that displayed no significant spatial
correlation between nearby spines. These
data suggest that the homeostatic type
of plasticity thought to be induced by
whisker trimming produces a more
global synaptic enrichment. A final exper-
iment was performed in mice with intact
whiskers, but with neocortical neurons
expressing a mutated form of AMPA
receptors that lack the appropriate phos-
phorylation site required for synaptic
incorporation (GluRAA). In this case, no
evidence of clustered synaptic plasticity
was observed.
Previous in vitro work has shown that
neurons possess mechanisms that could
act to produce compartmentalized formsecember 22, 2011 ª2011 Elsevier Inc. 887
